Prasugrel and ticagrelor: Equally safe and effective in STEMI
The antiplatelet drugs prasugrel and ticagrelor had similar safety and efficacy among patients with acute myocardial infarction and ST segment elevations (STEMI), according to results of PRAGUE-18, the first randomised, head-to-head ...
Aug 30, 2016
0
0